Delivery Order SPE2D020D0005-SPE2D324F036U
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,184.50, is a delivery order for the supply of 4,564,381,636 units of ondansetron ODT (orally disintegrating tablet) 4 mg, packaged in 30s. The contract is a firm fixed price agreement and has an ultimate completion date of April 29, 2024. Chartwell RX LLC is the prime contractor for this award,...
- This is a $1,776.75 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract is for the supply of 4 mg ondansetron orally disintegrating tablets in 30-count packages. This delivery order is issued under Chartwell RX's existing Indefinite Delivery Contract (SPE2D020D0005) with DLA, which enables the company to manufacture and distribute a broad range of...
- This is a firm-fixed-price delivery order contract awarded to Chartwell RX LLC, a for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ondansetron orally disintegrating tablets (8 mg, 30-count) to federal government agencies. The contract has a ceiling value of $1,973.10 and a period of performance ending on July 7, 2025. Chartwell RX LLC is a registered System for Award Management (SAM) vendor and has a history of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract, valued at $3,553.50, is for the supply of Ondansetron ODT 4 mg tablets to the agency. This contract is part of a larger Indefinite Delivery Contract (SPE2D020D0005) with the DLA Troop Support Medical, valued at over $7 million, which enables Chartwell RX to manufacture and distribute a broad...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $3,354.27 delivery order is for the supply of 4566683111 - Ondansetron ODT 8 mg Tablet in 30-count packages. The contract is a Firm Fixed Price Indefinite Delivery Vehicle (IDV) that allows Chartwell RX to manufacture and distribute a broad range of medications, including oral antibiotics, antivirals,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,842.80 firm fixed-price delivery order contract to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, which runs through August 2024, is for the provision of 4565467121 ondansetron orally disintegrating tablets (ODT) 4 mg. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) with Chartwell RX, valued at over $7 million and running through March 2030,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $1,302.95 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, an antiemetic medication, to support government healthcare services. The contract has an ultimate completion date of June 6, 2025. Chartwell RX LLC is an experienced federal contractor, holding multiple Indefinite...
- This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The contract is for the delivery of 8 mg ondansetron oral disintegrating tablets in 30-count packages, with a firm fixed price of $2,959.65 and a completion date of March 12, 2024. Chartwell RX is an experienced federal contractor, holding multiple indefinite delivery vehicle (IDV) contracts with the Department of Veterans...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, with an award value of $1,973.10, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at over $7 million, which enables Chartwell RX to manufacture and distribute a broad range of medications to military treatment facilities globally. The specific product being delivered...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract is for the supply of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The delivery order is valued at $5,922.50 and has a completion date of June 7, 2024. Chartwell RX LLC is the prime contractor and does not have any noted subcontractors. This contract is not set aside for any specific...
- SPE2D020D0005Indefinite Delivery Contract
- SPE2D020D0005-SPE2D324F036UDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,973.10, is for the delivery of 4,564,795,757 units of ondansetron ODT 8 mg tablets in 30-count packages. The contract has a firm fixed price pricing type and a completion date of June 7, 2024. Chartwell RX LLC is the prime contractor and has been awarded several other federal contracts, including a $7 million Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a $225,000 Federal Supply Schedule contract with the Department of Veterans Affairs. These contracts enable Chartwell RX to provide a wide range of pharmaceutical products to the government, including antibiotics, antivirals, and antifungals. The company has demonstrated its ability to reliably supply medications to support healthcare services for military personnel, veterans, and other government beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 6/4/24 |